APPLETON GROUP, LLC - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLV and the CUSIP is 81369Y209. A total of 1,181 filers reported holding SELECT SECTOR SPDR TR in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.5%.

Quarter-by-quarter ownership
APPLETON GROUP, LLC ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q4 2022$200,922
-23.3%
1,479
-22.8%
0.30%
-19.2%
Q1 2022$262,000
-7.4%
1,916
-4.8%
0.36%
+28.5%
Q4 2021$283,000
-3.1%
2,012
-12.3%
0.28%
+13.1%
Q3 2021$292,000
+0.3%
2,293
-0.6%
0.25%
+12.6%
Q2 2021$291,000
+10.2%
2,308
-0.9%
0.22%
-13.6%
Q4 2020$264,000
-27.1%
2,330
-35.6%
0.26%
-40.8%
Q2 2020$362,000
-32.5%
3,616
-31.3%
0.44%
-35.9%
Q4 2019$536,000
-12.1%
5,264
-22.2%
0.68%
-4.0%
Q3 2019$610,000
-2.1%
6,765
+0.7%
0.71%
+1.9%
Q2 2019$623,000
-6.2%
6,721
-7.1%
0.70%
+8.8%
Q1 2019$664,000
-15.6%
7,234
-12.5%
0.64%
-23.4%
Q3 2018$787,000
+15.6%
8,272
+1.3%
0.83%
-6.8%
Q2 2018$681,000
+4.3%
8,163
+1.7%
0.90%
+19.3%
Q1 2018$653,000
+3.2%
8,025
+4.9%
0.75%
+19.4%
Q4 2017$633,000
-1.4%
7,650
-2.6%
0.63%
-9.0%
Q3 2017$642,000
+9.0%
7,854
+5.7%
0.69%
+3.6%
Q2 2017$589,000
+32.7%
7,433
+24.4%
0.67%
+29.8%
Q1 2017$444,000
+102.7%
5,973
+88.4%
0.51%
+77.5%
Q4 2016$219,000
-0.5%
3,170
-7.9%
0.29%
+4.0%
Q3 2014$220,000
-4.3%
3,442
-9.1%
0.28%
+9.0%
Q2 2014$230,000
+5.0%
3,788
+1.1%
0.26%
-5.2%
Q1 2014$219,0003,7480.27%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q1 2021
NameSharesValueWeighting ↓
NIPPON LIFE INSURANCE CO 5,206,929$521,943,00011.82%
Main Management ETF Advisors, LLC 599,760$60,018,00011.33%
Florin Court Capital LLP 75,400$7,545,00010.89%
Miller Investment Management, LP 335,865$33,610,0009.88%
AGF Investments LLC 945,054$94,572,0009.61%
Annex Advisory Services, LLC 681,616$68,209,0009.51%
Optimum Quantvest Corp 44,715$4,475,0009.13%
Altus Wealth Management, LLC 77,341$7,739,0008.62%
Camarda Financial Advisors, LLC 58,740$5,878,0008.22%
Advisors Preferred, LLC 280,739$28,310,0007.90%
View complete list of SELECT SECTOR SPDR TR shareholders